Massart, J <br/><br/>
Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.  [electronic resource] 

 -  British journal of pharmacology  Mar 2012 
 - 1361-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/j.1476-5381.2011.01580.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipocytes--drug effects<br/>Animals<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Cell Line, Tumor<br/>Diabetes Mellitus, Type 2--genetics<br/>Fatty Liver--genetics<br/>Glucose--genetics<br/>Glucose Tolerance Test--methods<br/>Glucose Transporter Type 2--genetics<br/>Glycolysis--drug effects<br/>Humans<br/>Inflammation--genetics<br/>Intestinal Absorption--drug effects<br/>Jejunum--drug effects<br/>Lipids--blood<br/>Lipogenesis--drug effects<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Obese<br/>Nuclear Proteins--genetics<br/>Obesity--genetics<br/>Oxidative Stress--drug effects<br/>Pentoxifylline--pharmacology<br/>Sodium-Glucose Transporter 1--genetics<br/>Sterol Regulatory Element Binding Protein 1--genetics<br/>Transaminases--blood<br/>Transcription Factors--genetics<br/>Triglycerides--blood